Cell Biologique™ - London

I've reviewed hundreds of post-needling protocols over the years, and most describe products, timings, even client aftercare instructions in impressive detail.

But when I ask a simple question, the room goes quiet:

when does proliferation peak after needling?

Because if you can't answer that, you're not working with the biology. You're working around it.

Here's what I mean:

❌ evidence-based doesn't mean you attended a CPD course.
❌ it doesn't mean the brand sent you a white paper.
❌ it doesn't mean the protocol worked on your last three clients.

✅ evidence-based means you understand the cellular timeline.
✅ it means you know when inflammation should resolve.
✅ it means you can explain why you're applying that serum on day three, not just that the trainer told you to.

The proliferation phase begins around 48-72 hours post-injury and peaks between days 5-7. That's when fibroblast activity, collagen synthesis, and angiogenesis are at their highest.

If your protocol doesn't align with that window, you're guessing.

And guessing leads to inconsistent outcomes, frustrated clients, and that nagging feeling that maybe the results weren't as predictable as they should have been.

This is why I built the bioRegen framework around cellular recovery phases, not product categories. Because the biological response determines the outcome, not the procedure.

If this resonates, save this. I'll be unpacking the full wound-healing cascade and how to apply it clinically in upcoming posts.

This question reveals more about clinical reasoning than most continuing education courses.

Because the answer isn't either/or. It's sequential.

Barrier function tells you how vulnerable the skin is to the procedure you're about to perform. pH tells you whether the stratum corneum is primed to receive the peel evenly.

If you assess pH first but the barrier is compromised, you're stepping into unpredictable inflammatory territory. You might get absorption, but you're also inviting excessive reactivity, prolonged erythema, and inconsistent wound healing responses.

If you assess barrier function first, you're asking the right biological question before the aesthetic one: is this skin ready to handle controlled injury? Can it mount a predictable recovery response? Or are we layering stress onto an already dysregulated system?

That's the shift from trend-driven protocols to evidence-based clinical reasoning.

The procedure does not determine the outcome. The biological response determines the outcome.

If you're tired of inconsistent client outcomes and want to deepen your understanding of cellular recovery science, comment SCIENCE and I'll send you a framework that changes how you think about every treatment, not just peels.

I spent years adjusting concentrations, trying to predict which client would heal beautifully and which would struggle.

Same peel. Same percentage. Wildly different outcomes.

Because the percentage of the acid was never the variable that mattered most.

The biological response of the skin was.

When we dose peels by concentration alone, we're working from a product-centered framework. We're assuming the treatment determines the outcome.

But it doesn't.

The skin's ability to mount an appropriate inflammatory response, resolve that inflammation efficiently, and communicate effectively at the cellular level , that determines the outcome.

Two clients can receive the same 30% peel:

❌ client A has compromised barrier function, dysregulated inflammation, and poor cellular communication. Result: prolonged erythema, delayed recovery, potential pigmentation.

✅ client B has optimized cellular resilience, balanced inflammatory pathways, and strong repair mechanisms. Result: predictable healing, minimal downtime, improved skin architecture.

Same percentage. Different biology. Different outcome.

This is why we built the BioRegen™ Cellular Recovery Framework around four biological phases , protect, resolve, restore, remodel , not around ingredient percentages or treatment protocols.

Because when you understand the biology of healing, you stop chasing concentrations and start optimizing responses.

You move from hoping for consistency to creating the conditions for predictable recovery.

The shift isn't about abandoning percentages entirely. It's about recognizing that concentration is one variable in a much larger biological equation.

And the practitioners who grasp this distinction are the ones delivering the outcomes that build trust, referrals, and long-term skin health.

What's your primary metric for peel efficacy? Tell us below. 💭

I ran a poll last week asking what you thought mattered most when choosing a peel: percentage or pH.

62% voted percentage.

And I get it. We've been conditioned to think higher percentage = stronger result.

But when you look at what's actually happening at the cellular level, the story changes completely.

The percentage tells you how much acid is in the bottle. But pH tells you how many hydrogen ions are free to interact with the skin. And that's what drives the biological response.

A 30% glycolic at pH 3.5 behaves very differently from a 30% glycolic at pH 2.0. Same percentage. Completely different tissue response.

When we look at histological evidence, we see that wound-healing cascades, inflammation pathways, and cellular communication are all governed by the skin's immediate biological environment, not just the concentration on the label.

This is why two clients can receive the same peel at the same percentage and have wildly different outcomes. You're not controlling for the variable that actually matters: the biological response.

Once you understand the relationship between pH, free acid concentration, and tissue behaviour, you stop chasing percentages and start designing protocols around predictable recovery.

That's the shift from product-focused thinking to biology-focused reasoning.

Was your vote for percentage? This histology will change your mind. Follow for more deep dives. 🚀

I had a micropigmentation specialist message me last week asking why her client outcomes were so unpredictable.

Same technique. Same pigments. Same aftercare instructions.

But one client heals beautifully in seven days, while another is still red and swollen at day ten, with patchy retention at four weeks.

The answer isn't in the needle or the pigment.

It's in the biological state of the skin before you ever touch it.

Most micropigmentation protocols focus entirely on what happens during and after the procedure. But if the client's skin is already in a state of unresolved inflammation, you're working against their biology from the start.

Chronic low-grade inflammation disrupts cellular communication. It delays wound closure, prolongs erythema, and interferes with pigment integration. The procedure itself adds a controlled injury to an already compromised system.

This is why pre-procedure preparation matters more than most specialists realise.

When you resolve baseline inflammation first, you create the conditions for predictable healing. The biological response becomes more consistent. Downtime shortens. Pigment retention improves. Client satisfaction goes up.

This isn't about adding more steps for the sake of it. It's about understanding that the procedure does not determine the outcome. The biological response determines the outcome.

And you can influence that response before you ever pick up your machine.

If you work with micropigmentation clients and want a clear protocol for pre-procedure inflammation resolution, DM us 'MICRO' and I'll send it to you. 🔥

The first 72 hours post-peel are where outcomes are decided.

Not by the peel itself, but by how well the biological response is managed.

Most complications don't begin during the procedure. They begin when unresolved inflammation cascades into deeper tissue disruption, barrier dysfunction, and prolonged recovery.

This protocol card breaks down the exact sequence we recommend for inflammation control from day 0 to day 3. Each step is there for a biological reason, not a cosmetic one.

Here's what matters most:

day 0 (immediately post-procedure): protect the barrier and deliver immediate anti-inflammatory support. The skin is in acute inflammatory phase. Cellular communication is disrupted. Your role is to calm that response before it escalates.

Day 1-2: resolve ongoing inflammation while supporting barrier integrity. This is where most practitioners lose control. If inflammation persists beyond 48 hours, you're no longer in the protective window. You're managing a complication.

Day 3: transition from acute recovery to active restoration. The biological environment should now support cellular regeneration, not fight lingering damage.

The framework we use is simple: PROTECT, RESOLVE, RESTORE, REMODEL. But the ex*****on requires clinical reasoning, not just product application.

Every recommendation in this protocol ties back to wound-healing science and cellular communication pathways. It's designed to create predictable outcomes, even when patient variables differ.

Screenshot this for your clinic and follow for more protocol insights! 🌱

For years, the aesthetic industry has equated success with stimulation.

More collagen. More fibroblast activity. More growth factors.

But here's the biological truth most protocols miss: stimulation without resolution doesn't create resilient skin. It creates inflammation that never fully resolves.

Think about what happens after any aesthetic procedure. The tissue enters an inflammatory state. That's normal. That's necessary.

But if that inflammation doesn't transition cleanly through resolution, the wound-healing cascade stalls. You get prolonged redness, unpredictable texture, delayed recovery, and outcomes that look good initially but don't hold.

The biological response determines the outcome. Not the procedure itself.

So when we design protocols, the question isn't just 'how do we stimulate collagen?' It's 'how do we support the skin's ability to resolve inflammation predictably, so the remodelling phase can begin on time, with the right signals?'

That's where the science of cellular communication becomes critical. Resolution isn't passive. It's an active biological process that requires the right lipid mediators, the right signalling molecules, and the right cellular environment.

When resolution happens cleanly, you see faster recovery, fewer complications, and skin that rebuilds with structural integrity.

When it doesn't, you see the inconsistency we've all experienced clinically.

This is the shift from biology before beauty. Not chasing trends. Not layering actives without understanding the cascade. But building protocols that respect the wound-healing timeline and support each phase with clinical reasoning.

Is your current protocol focused on stimulation or resolution? Discuss below. 💭

I used to believe smaller molecules meant faster pe*******on and better results.

Then I watched a client's skin take three weeks to recover from a series of 30% glycolic peels.

The biology told a different story.

Glycolic acid has the smallest molecular weight of all alpha hydroxy acids. That's usually marketed as an advantage. But that same characteristic drives a more aggressive inflammatory response.

Here's what happens at the cellular level:

smaller molecules pe*****te deeper and faster, yes. But they also disrupt the lipid barrier more extensively. Your client's skin recognises this as a threat. Inflammatory cytokines flood the area. The protective barrier is compromised before the cellular communication pathways can organise an efficient repair response.

The result? Prolonged erythema. Extended downtime. Unpredictable healing patterns.

I'm not saying glycolic has no place in your treatment room. I'm saying the conversation needs to shift from pe*******on speed to biological response.

When you understand wound healing science, you start asking different questions:

• how is this affecting barrier integrity?
• what inflammatory cascade am I triggering?
• does my client's skin have the cellular resources to resolve this efficiently?
• what am I doing to support the biological recovery process?

This is where the science separates from the marketing.

Recovery-first protocols don't avoid exfoliation. They sequence it intelligently. They prime the skin's cellular communication networks. They provide the molecular building blocks for efficient resolution and remodelling.

Because the acid doesn't determine the outcome.

The biological response determines the outcome.

Do you prioritise molecule size in your acid selection? Share your insights.